Dr. Reddy's receives approval for aspirin and extended-release dipyridamole
Dr. Reddy’s Laboratories Ltd. has announced receipt of approval from the US FDA for aspirin and extended-release dipyridamole capsules in the US market. The drug is a therapeutic equivalent generic version of Aggrenox capsules from Boehringer Ingelheim, and will be made available in 25 mg/200 mg strength with 60 count bottle size.
The Aggrenox brand and generic had US sales of approximately $183-mn for the most recent 12 months ending in August 2018 according to IMS Health.
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
2026-08-09
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Congo Copper and Cobalt Miners Are Being Forced to Cut Chemical Use as Middle East Conflict Hits the New Energy Supply Chain
-
China’s PPI Finally Hits the Brakes — But the Pain Isn’t Over
-
BP Kicks Off $25 Billion Redevelopment of Iraq’s Kirkuk Oilfields
-
Refining at a Crossroads: Asia and the Middle East Expand While the West Retreats
-
Europe’s Chemicals Industry Stalls Again as Cefic Cuts 2025 Outlook
-
LG Chem and GS Caltex in Talks to Merge Yeosu Cracker Assets as Korea Pushes Industry Restructuring
-
The Great Hydrogen Reality Check: Global Clean Hydrogen Projects Face Mass Cancellations
-
Europe’s Recycling Industry in Crisis: Cheap Imports and Red Tape Push Plastic Recyclers to the Brink
-
ConocoPhillips to Cut Up to 25% of Workforce as Oil Price Slump Bites
-
Evonik Starts Up 100,000 t/y Alkoxylates Plant in Singapore to Meet Surging Asian Demand
Recommend Reading
-
Saudi Aramco’s 400,000 bpd Jazan Refinery Shuts After Attack
-
USDA Puts Fresh Money Into Local Food Markets
-
Lubrizol Announces Elimination of PFAS from Its Peptide Synthesis Process
-
Qatar LNG Hit by Attack: 17% Export Capacity Lost, $20 Billion Wiped Out
-
Vietnam Drives ASEAN Towards a Modern Economy
-
Coke Market Mostly Stabilizes, with Relatively Light Trading Activity
-
Melamine Stops Falling and Begins to Rebound; Short-Term Trend Strengthens; Golden Cross Awaits Confirmation
-
US-Iran Signals Easing, Plasticizer Supply Chain Stabilizes
-
U.S. Exempts Critical Chemical Manufacturers from Emissions Rules for Two Years
-
July Titanium Dioxide Market Prices Decline